Long-lasting neuropsychiatric side-effects from mefloquine prophylaxis: A case arising after six weeks and lasting for six months;Langvarige neuropsykiatriske bivirkninger efter meflochinprofylakse: Et seks maneder varende tilfoelde opstaet efter seks ugers brug

Ugeskrift for Laeger

Volumn 161, Issue 10, 1999, Pages 1422-1423

  Bygbjerg, Ib Christian ^a   Rønn, Anita Mandrup ^b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

MEFLOQUINE;

ADULT; ARTICLE; CASE REPORT; CHEMOPROPHYLAXIS; FEMALE; HOSPITALIZATION; HUMAN; MALARIA; MENTAL DISEASE; NEUROLOGIC DISEASE;

ADULT; ANTIMALARIALS; ANXIETY DISORDERS; BRAIN DISEASES; FEMALE; HEADACHE; HUMANS; MEFLOQUINE; MENTAL DISORDERS; NEUROLOGIC EXAMINATION; TIME FACTORS; VISION DISORDERS;

EID: 0033535390     PISSN: 00415782     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Rønn AM, Bygbjerg IC. Akut hjernesyndrom efter meflochinbehandling. Ugeskr Læger 1994; 156: 6044-5.
2. Rønn AM, Rønne-Rasmussen J, Gøtzsche P, Bygbjerg IC. Neuropsychiatric manifestations after mefloquine therapy for Plasmodium falciparum malaria: comparing a retrospective and a prospective study. Trop Med Int Health 1998; 2: 83-8.
3. WHO. International travel and health. Vaccination requirements and health advice. Genève: WHO, 1990.
4. Bradley DJ, Warhurst DC, on behalf of a meeting convened by the Malaria Reference Laboratory. Malaria prophylaxis: guidelines for travellers from Britain. BMJ 1995; 310: 709-14.
5. Statens Serum Institut. Vaccinationsforslag ved udlandsrejse 1995. EPI-NYT1996; uge 44a.
6. Hoffmann La Roche. Review of adverse events associated with Lariam (mefloquine) 1996. Basel: Hoffmann La Roche, 1997.
7. Bradley DJ, Warhurst DC. Guidelines for the prevention of malaria in travellers from the United Kingdom. PHLS Malaria Reference Laboratory, London School of Hygiene and Tropical Medicine. Commun Dis Rep CDR Rev 1997; 10: 137-52.
8. WHO. International travel and health. Vaccination requirements and health advice. Genève: WHO, 1997.
9. Huzly D, Schönfeld C, Beurle W, Bienzle, U. Malaria chemoprophylaxis in German tourists: a prospective study on compliance and adverse reactions. J Travel Med 1996; 3: 148-55.
10. Steffen R, Heusser R, Mächler R, Bruppacher R, Naef U, Chen D et al. Malaria chemoprophylaxis among European tourists in tropical Africa: use, adverse reactions, and efficacy. Bull World Health Org 1990; 68: 313-22.
11. Statens Serum Institut. Malaria 1997. EPI-NYT 1998; uge 15/16.